<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00968903</url>
  </required_header>
  <id_info>
    <org_study_id>H-A-2008-030</org_study_id>
    <secondary_id>2009-41-3784</secondary_id>
    <secondary_id>2612-3916</secondary_id>
    <secondary_id>EudraCT: 2008-006528-67</secondary_id>
    <nct_id>NCT00968903</nct_id>
  </id_info>
  <brief_title>Effects of Methylprednisolone After Total Hip Arthroplasty</brief_title>
  <official_title>Effects of Pre-operative Methylprednisolone (125mg iv) After Total Hip Arthroplasty: A Prospective, Randomized, Double-blind, Placebo-controlled Trail</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hvidovre University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Lundbeck Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hvidovre University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to compare the effects of pre-operative methylprednisolone (125mg
      iv) versus placebo on postoperative outcome after hip arthroplasty.

      The hypothesis is that pre-operative methylprednisolone (125mg iv) will reduce time to
      fulfill discharge criteria.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In spite of being one of the last century's most successful surgical procedures in treatment
      of advanced osteoarthritis total hip arthroplasty is still associated with postoperative pain
      and delayed rehabilitation. The investigators therefore decided to evaluate the effects of
      pre-operative methylprednisolone (125mg iv) versus placebo on postoperative outcome in a well
      defined fast-track setup after hip arthroplasty.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2010</start_date>
  <completion_date type="Actual">January 2011</completion_date>
  <primary_completion_date type="Actual">January 2011</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to fulfill discharge criteria</measure>
    <time_frame>At discharge (mean 1-2 days)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hand muscle strength</measure>
    <time_frame>24 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleeping quality on the visual analog scale</measure>
    <time_frame>up to four days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inflammatory response measured as CRP in blood sample</measure>
    <time_frame>24 hours postoperatively</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fatigue measured on a 10 point numeric range scale</measure>
    <time_frame>up to four days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Additional analgetics, antinausea agents and sleeping medicine.</measure>
    <time_frame>up to four days</time_frame>
    <description>Measures as mg (analgetics) and daily use (yes or no)(antinausea agents and sleeping medicine).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants with Adverse Events as a Measure of Safety and Tolerability</measure>
    <time_frame>up to 30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative pain scores on the visual analog scale</measure>
    <time_frame>up 30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative nausea and vomiting (PONV) on 4 point numeric range scale</measure>
    <time_frame>up to 4 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">48</enrollment>
  <condition>LOS</condition>
  <condition>Postoperative Pain</condition>
  <condition>Postoperative Nausea and Vomiting</condition>
  <condition>Sleeping Quality</condition>
  <condition>Fatigue</condition>
  <condition>Inflammatory Response</condition>
  <arm_group>
    <arm_group_label>Methylprednisolone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Methylprednisolone 125 mg iv pre-operatively</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Saline iv pre-operatively in equivalent volume (placebo)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Methylprednisolone</intervention_name>
    <description>Methylprednisolone 125 mg iv pre-operatively</description>
    <arm_group_label>Methylprednisolone</arm_group_label>
    <arm_group_label>Saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Elective total hip arthroplasty

          -  Able to speak and understand danish

          -  Able to give informed consent

        Exclusion Criteria:

          -  Alcohol or medical abuse

          -  Allergies to local anesthetics or methylprednisolone

          -  Age &lt; 18 years

          -  Daily use of opioids or glucocorticoids

          -  Pregnancy or breastfeeding (fertile women)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hvidovre University Hospital</name>
      <address>
        <city>Copenhagen</city>
        <state>Hvidovre</state>
        <zip>2650</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>September 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 28, 2009</study_first_submitted>
  <study_first_submitted_qc>August 28, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 31, 2009</study_first_posted>
  <last_update_submitted>September 28, 2011</last_update_submitted>
  <last_update_submitted_qc>September 28, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 29, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hvidovre University Hospital</investigator_affiliation>
    <investigator_full_name>Troels Haxholdt Lunn</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Hip arthroplasty</keyword>
  <keyword>Methylprednisolone</keyword>
  <keyword>Post-operative pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fatigue</mesh_term>
    <mesh_term>Pain, Postoperative</mesh_term>
    <mesh_term>Vomiting</mesh_term>
    <mesh_term>Postoperative Nausea and Vomiting</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prednisolone acetate</mesh_term>
    <mesh_term>Methylprednisolone acetate</mesh_term>
    <mesh_term>Methylprednisolone</mesh_term>
    <mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
    <mesh_term>Prednisolone</mesh_term>
    <mesh_term>Prednisolone hemisuccinate</mesh_term>
    <mesh_term>Prednisolone phosphate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

